Skip to content
Search

Latest Stories

Labour Party joins calls for probe into higher ethnic minority deaths

The Labour Party on Saturday (11) joined calls alongside doctors doctors for a probe into the disproportionate number of black and minority ethnic (BAME) medics dying from the novel coronavirus in the country.

The move comes as UK health secretary Matt Hancock confirmed that 19 NHS workers have died with coronavirus since the outbreak began, around 10 of whom were of BAME backgrounds.


"The disproportionate number of BAME doctors who have died from coronavirus is deeply disturbing," said Marsha de Cordova, Labour's shadow women and equalities secretary.

"It reflects the shocking underlying inequalities facing BAME communities as a whole - who are disproportionately represented in the numbers of people getting the virus. The government must urgently investigate why BAME communities are more vulnerable to this virus," she said.

The shadow minister's intervention came as the British Medical Association (BMA) doctors' union and the British Association of Physicians of Indian Origin (BAPIO) also called for similar in-depth research and investigation.

"We have heard the virus does not discriminate between individuals but there's no doubt there appears to be a manifest disproportionate severity of infection in BAME people and doctors.

"This has to be addressed - the government must act now," said Dr Chaand Nagpaul, BMA council chair, alongside a wider plea for better access to personal protective equipment (PPE) for medics working on the frontlines of the pandemic in NHS hospitals.

While it remains unclear whether the lack of PPE is directly linked to the recorded deaths of doctors in the UK so far, the BMA council chief urged action on assessing the factors behind the large numbers of BAME doctors and nurses among the victims of the deadly virus.

It comes days after BAPIO wrote to the chief medical officer of England, professor Chris Whitty, and medical director of NHS England Stephen Powis requesting all the official data available on COVID-19 hospital admissions for an in-depth research into the greater susceptibility of BAME patients developing more severe symptoms of coronavirus and dying of COVID-19.

BAPIO said: "We need a better understanding of the issues of BAME mortality in the context of the general population, particularly if it helps us manage sick and vulnerable groups, and so that we can be accurate in our messaging.

"We are therefore asking that the data for COVID-19 cases, and most certainly those who have died as a result of the illness, incorporates ethnicity and profession, as well as the usual demographic data."

A cardiac surgeon from Wales, 58-year-old Jitendra Kumar Rathod, originally from Gujarat, and Birmingham-based Hamza Pacheeri, 80, from Kerala are among the Indian-origin doctors who have died of coroavirus.

Indian-origin doctors make up a major chunk of the NHS workforce in the UK and BAPIO, their representative group, is urging the authorities to deploy senior and retired medics away from frontline duties until more evidence can be collated on the ethnic variables for COVID-19.

The UK's Department of Health has said it is working to protect all communities and has repeatedly pledged a boost to PPE supplies for NHS medical staff.

More For You

Camellia Panjabi's cookbook elevates
vegetables from sides to stars

Camellia Panjabi (Photo: Ursula Sierek)

Camellia Panjabi's cookbook elevates vegetables from sides to stars

RESTAURATEUR and writer Camellia Panjabi puts the spotlight on vegetables in her new book, as she said they were never given the status of a “hero” in the way fish, chicken or prawns are.

Panjabi’s Vegetables: The Indian Way features more than 120 recipes, with notes on nutrition, Ayurvedic insights and cooking methods that support digestion.

Keep ReadingShow less
Spotting the signs of dementia

Priya Mulji with her father

Spotting the signs of dementia

How noticing the changes in my father taught me the importance of early action, patience, and love

I don’t understand people who don’t talk or see their parents often. Unless they have done something to ruin your lives or you had a traumatic childhood, there is no reason you shouldn’t be checking in with them at least every few days if you don’t live with them.

Keep ReadingShow less
HH Guruji performed the Dhwaja Ritual at Ambaji Temple

HH Guruji performed the Dhwaja Ritual at Ambaji Temple

Mahesh Liloriya

The holy town of Ambaji witnessed a spiritually significant day on Sunday as His Holiness Siri Rajrajeshwar Guruji, head of the International Siddhashram Shakti Centre, London, performed the Dhwaja ritual at the historic Ambaji Temple in Gujarat, one of the most revered Shakti Peeths of India.

Keep ReadingShow less
Eco-friendly Ganesh Utsav at Harrow’s Siddhashram Shakti Centre

Eco-friendly Ganesh Utsav at Harrow’s Siddhashram Shakti Centre

Mahesh Liloriya

The International Siddhashram Shakti Centre in Harrow witnessed an inspiring and environmentally responsible celebration of Ganesh Utsav 2025, which concluded on Saturday, 6 September, with the Ganesh Visarjan ritual performed on the sacred occasion of Anant Chaturdashi.

Keep ReadingShow less
Mounjaro price rise

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro

iStock

Mounjaro’s highest dose to rise from £122 to £247.50, not £330

Highlights:

  • Eli Lilly had announced a steep price rise of up to 170% for Mounjaro.
  • A new discount deal with UK suppliers will limit the increase for patients.
  • Pharmacies will still apply a mark-up, but consumer costs are expected to rise less than initially feared.
  • NHS pricing remains unaffected due to separate arrangements.

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro, easing fears of a sharp rise in costs for UK patients. The new arrangement means that, from September, pharmacies and private services will face smaller wholesale increases than first expected, limiting the impact on consumers.

Why the price rise was announced

Earlier this month, Eli Lilly said it would raise Mounjaro’s list price by as much as 170%, which could have pushed the highest monthly dose from £122 to £330. The company argued that UK pricing needed to align more closely with higher costs in Europe and the United States.

Keep ReadingShow less